Carregant...
New Strategies in Metastatic Hormone Receptor-Positive Breast Cancer: Searching for Biomarkers to Tailor Endocrine and other Targeted Therapies
While major advances in our understanding of the molecular underpinnings of hormone receptor-positive (HR-positive) breast cancer have led to new therapies that have substantially improved in patient outcomes, endocrine–resistant disease still remains a leading cause of breast cancer mortality. Comp...
Guardat en:
| Publicat a: | Clin Cancer Res |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5350010/ https://ncbi.nlm.nih.gov/pubmed/27979914 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-0591 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|